dihydro-4-oxoquinolin-6-yl)acetamide (1), a key intermediate for the synthesis of selective EGFR kinase inhibitors, was described. Figure 1 ) was a key intermediate for either EKB-569 (2) or neratinib (3) , both of which were developed as dual irreversible inhibitors of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor-2 (EGFR-2) protein tyrosine kinases. 6 In the previous reports, 1 was prepared using 2-amino-5-nitrophenol (4) as starting material. 5 was synthesized by acelytion, ethylation and reduction of 4 (Scheme 1), and then reacted with ethyl (E)-2-cyano-3-ethoxypropenoate to furnish 6. In the following thermal cyclization, the reaction mixture was heated at 260 °C for 20 h to give 1 with 35% yield.
N-(3-Cyano-7-ethoxy-1,4-
dihydro-4-oxoquinolin-6-yl)acetamide (1, Figure 1 ) was a key intermediate for either EKB-569 (2) or neratinib (3) , both of which were developed as dual irreversible inhibitors of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor-2 (EGFR-2) protein tyrosine kinases. 6 In the previous reports, 1 was prepared using 2-amino-5-nitrophenol (4) as starting material. An efficient and mild synthesis for 1 is needed in the process for 2 and 3. To address this issue, we conceived an alternative strategy using compound 7 as starting material. Herein, we wish to report this approach as a new mild promising method for the preparation of compound 1.
We noted that Atkins Esterfication of 7 followed by acetylation gave 9 in 87% yield. Ethylation of 9 followed by hydrolysis afforded the substituted benzoic acid 11, whose treatment with fuming nitric acid produced compound 12. By treating 12 with SOCl 2 and following reaction with ethyl cyanoacetate, the synthesis of compound 13 was achieved in excellent yield (90%) by two steps. Treatment of 13 in DMSO/H 2 O provided the compound 14 in 84% yield. Condensation of 14 with DMF-DMA gave compound 15. The next reductive cyclization of 15 was achieved with zinc-acetic acid-ethanol system to give 1 in good yield. Because the sodium salt form of 1 can dissolve in the mixture of ethanol and water, it is ready to give 1 in satisfying HPLC purity (99.20%) by simple alkalization, acidification and filtration.
Finally, the overall yield of this reductive cyclization process was about 31% (from 7) over ten steps.
EXPERIMENTAL
All commercially available materials and solvents were used as received products without further purification.
1
H NMR spectra were recorded on a Varian Gemini 300 spectrometer and 13 C NMR spectra were obtained from a Bruker AMX 400/600 spectrometer at 400 MHz using TMS as an internal standard. 
3-Acetamido-4-ethoxybenzoic acid (11)
To a stirred solution of 10 (3. 
5-Acetamido-4-ethoxy-2-nitrobenzoic acid (12)
To a stirred solution of 11 (3. 
N-[5-(2-Cyanoacetyl)-2-ethoxy-4-nitrophenyl]acetamide (14)
A mixture of 13 ( 
N-{5-[2-Cyano-3-(N,N-dimethylamino)acryloyl]-2-ethoxy-4-nitrophenyl}acetamide (15)
To a stirred suspension of 14 (0.7 kg, 2.0 mol) in DME (6 L) was added DMF-DMA (0.4 L, 3.0 mol). The mixture was stirred at room temperature for 1 h. 
